DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Smith MR. et al.
Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial.
Lancet 2012;
379: 39-46
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.